Cerity Partners LLC Takes $227,000 Position in Exponent, Inc. (NASDAQ:EXPO)

Cerity Partners LLC bought a new stake in shares of Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,581 shares of the business services provider’s stock, valued at approximately $227,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in EXPO. Parkside Financial Bank & Trust lifted its holdings in Exponent by 10.5% in the 3rd quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock valued at $126,000 after purchasing an additional 140 shares in the last quarter. Quadrature Capital Ltd lifted its holdings in Exponent by 6.7% in the 3rd quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock valued at $210,000 after purchasing an additional 155 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in Exponent by 1.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 12,442 shares of the business services provider’s stock valued at $1,065,000 after purchasing an additional 207 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Exponent by 6.5% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 3,482 shares of the business services provider’s stock valued at $298,000 after purchasing an additional 212 shares in the last quarter. Finally, Advisor Partners II LLC lifted its holdings in Exponent by 6.0% in the 3rd quarter. Advisor Partners II LLC now owns 3,771 shares of the business services provider’s stock valued at $323,000 after purchasing an additional 215 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Down 2.1 %

NASDAQ EXPO opened at $93.20 on Tuesday. Exponent, Inc. has a 52 week low of $64.61 and a 52 week high of $102.72. The business’s fifty day simple moving average is $80.23 and its 200-day simple moving average is $81.85. The firm has a market cap of $4.72 billion, a PE ratio of 47.07 and a beta of 0.68.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, topping the consensus estimate of $0.46 by $0.13. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The business had revenue of $137.21 million for the quarter, compared to analyst estimates of $125.98 million. During the same quarter in the previous year, the firm earned $0.56 EPS. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. Research analysts expect that Exponent, Inc. will post 1.76 EPS for the current year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Friday, June 7th. Exponent’s payout ratio is 56.57%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on EXPO shares. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th. Truist Financial lifted their price target on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Monday.

Insider Buying and Selling

In related news, insider Eric Guyer sold 3,367 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $78.49, for a total transaction of $264,275.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.